Noveome Biotherapeutics has filed a notice of an exempt offering of securities to raise $40,190,480.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Noveome Biotherapeutics is raising $40,190,480.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Patrick Welch played a key role…
